# OLD MARKET CAPITAL Corp: overview

OMCC · OTC · CIK 1000045 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/omcc.md) · [Financials](/companies/omcc/financials.md) · [Filings](/companies/omcc/filings.md) · [Insiders](/companies/omcc/insiders.md)

Latest reported revenue: [$3.2m](/filings/0001437749-25-035199.md) for Q2 FY2026, three months to 2025-09-30, from the 10-Q filed Nov 14, 2025 (XBRL us-gaap:Revenues, accession 0001437749-25-035199).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [0.0](/filings/0000950170-25-021128.md) | [0.0 d](/filings/0000950170-25-091151.md) | [489](/filings/0000950170-25-108819.md) | [2,958](/filings/0000950170-24-126356.md) | [2,968](/filings/0000950170-25-021128.md) | [2,951 d](/filings/0000950170-25-091151.md) | [3,034](/filings/0000950170-25-108819.md) | [3,159](/filings/0001437749-25-035199.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | [(730.3%)](/filings/0000950170-25-108819.md) | [(42.7%)](/filings/0001437749-25-035199.md) | [(23.7%)](/filings/0000950170-25-021128.md) | [(48.2%) d](/filings/0000950170-25-091151.md) | [(32.5%)](/filings/0000950170-25-108819.md) | [(30.5%)](/filings/0001437749-25-035199.md) |
| Net margin | % | not reported | not reported | [(675.3%)](/filings/0000950170-25-108819.md) | [(23.0%)](/filings/0001437749-25-035199.md) | [(6.3%)](/filings/0000950170-25-021128.md) | [(35.0%) d](/filings/0000950170-25-091151.md) | [(24.7%)](/filings/0000950170-25-108819.md) | [(23.8%)](/filings/0001437749-25-035199.md) |
| Diluted EPS | $ per share | [(1.60)](/filings/0000950170-25-021128.md) | not reported | [(0.49)](/filings/0000950170-25-108819.md) | [(0.10)](/filings/0001437749-25-035199.md) | [(0.04)](/filings/0000950170-25-021128.md) | not reported | [(0.11)](/filings/0000950170-25-108819.md) | [(0.11)](/filings/0001437749-25-035199.md) |
| Free cash flow | $k | [(431) d](/filings/0000950170-25-021128.md) | [792 d](/filings/0000950170-25-091151.md) | [(807)](/filings/0000950170-25-108819.md) | [(3,665) d](/filings/0001437749-25-035199.md) | [(2,901) d](/filings/0000950170-25-021128.md) | [(2,943) d](/filings/0000950170-25-091151.md) | [(2,819)](/filings/0000950170-25-108819.md) | [(4,904) d](/filings/0001437749-25-035199.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-03-31) | FY2022 (2022-03-31) | FY2023 (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [56.0](/filings/0000950170-22-012061.md) | [49.8](/filings/0000950170-23-030037.md) | [44.3](/filings/0000950170-23-030037.md) | [0.0](/filings/0000950170-25-091151.md) | [9.4](/filings/0000950170-25-091151.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | [(74.3%)](/filings/0000950170-25-091151.md) |
| Net margin | % | [14.9%](/filings/0000950170-22-012061.md) | [6.0%](/filings/0000950170-23-030037.md) | [(77.0%)](/filings/0000950170-24-079650.md) | not reported | [(55.0%)](/filings/0000950170-25-091151.md) |
| Diluted EPS | $ per share | [1.09](/filings/0000950170-22-012061.md) | [0.39](/filings/0000950170-23-030037.md) | [(4.65)](/filings/0000950170-24-079650.md) | [(2.86)](/filings/0000950170-25-091151.md) | [(0.77)](/filings/0000950170-25-091151.md) |
| Free cash flow | $m | [13.8](/filings/0000950170-22-012061.md) | [2.2](/filings/0000950170-23-030037.md) | [(2.2)](/filings/0000950170-24-079650.md) | [1.8](/filings/0000950170-25-091151.md) | [(10.3)](/filings/0000950170-25-091151.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/omcc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

None of the funds in coverage reports a position in its latest 13F.

## Recent filings

[All 690 filings](/companies/omcc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2025-12-11 | 16:05 ET | [8-K](/filings/0001437749-25-037549.md) | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037549 |
| 2025-12-10 | 16:12 ET | [8-K](/filings/0001437749-25-037398.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-037398 |
| 2025-12-02 | 16:43 ET | [8-K](/filings/0001437749-25-036667.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001437749-25-036667 |
| 2025-11-14 | 16:24 ET | [10-Q](/filings/0001437749-25-035199.md) | Quarterly report, period 2025-09-30 | 0001437749-25-035199 |
| 2025-11-14 | 16:24 ET | [8-K](/filings/0001437749-25-035202.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-035202 |
| 2025-09-12 | 18:44 ET | [SCHEDULE 13D](/filings/0001104659-25-089649.md) | Ownership report, active investor | 0001104659-25-089649 |
| 2025-09-12 | 19:30 ET | [8-K](/filings/0001193125-25-201492.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-201492 |
| 2025-08-14 | 16:00 ET | [10-Q](/filings/0000950170-25-108819.md) | Quarterly report, period 2025-06-30 | 0000950170-25-108819 |
| 2025-08-14 | 16:00 ET | [8-K](/filings/0000950170-25-108818.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-108818 |
| 2025-07-29 | 17:14 ET | [DEF 14A](/filings/0000950170-25-099736.md) | Proxy statement, period 2025-09-08 | 0000950170-25-099736 |

## Latest annual report

[Form 10-K for the fiscal year ended Mar 31, 2025](/filings/0000950170-25-091151.md), filed Jun 30, 2025.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1000045
- Tickers: OMCC
- Exchange: OTC
- SIC code: 6153 Short-Term Business Credit Institutions
- State of incorporation: FL
- Filer category: Non-accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:29 ET. No prices; not investment advice.
